Neuroinflammation has emerged as a critical area of concern in recent months, particularly in the UK, where an increasing number of individuals are grappling with neuropsychiatric disorders post-COVID. These disorders, often referred to as PANDAS and PANS, gained significant attention in April 2023 when the Academy of Nutritional Medicine (AONM) highlighted a surge in cases in its newsletter. This concern has since escalated, prompting a Parliamentary Debate on September 12th, following the successful launch of